Health
Health and Life Sciences
Advance research and innovation in health and the life sciences through European funding programmes. We support universities, research organisations, healthcare providers, SMEs and industry in developing competitive projects across biotechnology, medical technologies, diagnostics, therapeutics, digital health, personalised medicine and advanced therapies. Our expertise spans Horizon Europe (Cluster 1 Health and EU Mission: Cancer), the Innovative Health Initiative (IHI), EDCTP3, EIC, MSCA and other European research and innovation programmes.
Ready to get started?
We provide expert support for every stage of your European research and innovation project.
Dr. Jeanette Müller
CEO
Funded projects
Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome
Programme:
H2020-SC1-2019
Area:
Health, exposome, immunology
Budget:
10.8 million euro
Duration:
01.01.2020 – 30.06.2025
Next-generation scientists studying extracellular RNA
Programme:
HORIZON-MSCA-DN
Area:
Health, Life Sciences
Budget:
3.34 million euro
Duration:
01.02.2027 – 31.01.2031
Developing and implementing innovative Patient-Centred Care Pathways for cancer patients
Programme:
HORIZON-HLTH-2021-DISEASE
Area:
Health, cancer care, ICT
Budget:
6.5 million euro
Duration:
01.09.2022 – 31.08.2027
Open calls
Here are some of the many EU funding opportunities we can help you succeed in.
HORIZON-HLTH-2027-01-DISEASE-08
Development of innovative antimicrobials against pathogens resistant to antimicrobials
Horizon Europe
Cluster 1 – Health
RIA
Deadline
17.02.2027, 17:00
Budget
€ 8 - 10 million
Single-stage
Our experience
See our track record in this area.
HORIZON-HLTH-2027-01-ENVHLTH-02
Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
Horizon Europe
Cluster 1 – Health
RIA
Deadline
17.02.2027, 17:00
Budget
€ 10 - 11 million
Single-stage
Our experience
See our track record in this area.
HORIZON-HLTH-2027-01-DISEASE-05
Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Horizon Europe
Cluster 1 – Health
RIA
Deadline
17.02.2027, 17:00
Budget
€ 9 - 11 million
Single-stage
Our experience
See our track record in this area.
What our clients say
“Collaborating with accelopment has been a fantastic experience. Their expertise and support were crucial to the success of my two MSCA Doctoral Network projects, MITGEST and INT2ACT. Working with them is a real pleasure!“
Prof. Carlo Vascotto
INT2ACT Project Coordinator, MITGEST Project Coordinator
University of Udine, Italy
University of Udine, Italy

Programme:
HORIZON-MSCA-DN
Duration:
01.10.2022 - 31.01.2027
Area:
Health, chemistry, gene therapy
Budget:
2.56 million euro
Frequently asked questions
Health research and innovation is supported through several European funding programmes and initiatives. Horizon Europe Cluster 1 Health is a major source of funding, complemented by instruments such as the EU Mission on Cancer and European Partnerships. Funding topics cover areas ranging from disease prevention, diagnosis and treatment to personalised medicine, digital health, healthcare systems and environmental influences on health. accelopment helps research organisations and companies identify suitable opportunities and develop competitive European research and innovation projects.
accelopment supports researchers and organisations throughout the development of Horizon Europe Health proposals. Depending on the consortium's needs, this can include analysing the call topic, developing the proposal strategy and structure, coordinating contributions from consortium partners, supporting proposal writing and reviewing the application against Horizon Europe evaluation criteria. Particular attention is given to the project's expected outcomes and impacts, implementation approach and measures for communication, dissemination and exploitation. The objective is to turn a strong scientific concept into a coherent and convincing European research and innovation proposal.
accelopment supports collaborative European research and innovation projects addressing a broad range of health and life sciences challenges. These include areas such as cancer, infectious and chronic diseases, personalised medicine, diagnostics, medical technologies, digital health, patient-centred care and the environmental determinants of health. Our role complements the scientific and clinical expertise of project partners with expertise in EU funding, proposal development, project management, communication, dissemination, exploitation and innovation management.
Communication, dissemination and exploitation help translate health research into benefits for patients, healthcare professionals, policymakers, industry and society. A strong strategy identifies the project's different target groups, defines how results will be shared with them and establishes pathways for the uptake and use of those results. In health projects, this can include scientific dissemination, stakeholder and patient engagement, policy communication, exploitation of technologies or methodologies and support for clinical or market-oriented pathways. These activities contribute directly to the credibility of the project's expected impact.
Yes. accelopment supports EU-funded research and innovation projects during implementation as well as during proposal development. Depending on the project, this can include project management and coordination support, internal consortium processes, reporting, communication and dissemination, stakeholder engagement, exploitation activities and innovation management. Having these functions professionally managed helps scientific and clinical partners concentrate more of their resources on research and innovation activities while maintaining compliance with Horizon Europe requirements.